Bipolar I
Resources for Patients and Caregivers
Bipolar I Disorder— defined by manic episodes that last at least 7 days, or by manic symptoms that are so severe that the person needs immediate hospital care. Usually, depressive episodes occur as well, typically lasting at least 2 weeks.
Cluster Number:
Wiki Number: 08-Bipolar I
Diagnosis: This requires just one full manic episode where the individual may be “high” for several days.
US Patients: 1% of the US population in their lifetimes.
World Patients:
Sex Ratio:
Age Onset:
Brain Area:
Symptoms: Typically it will be followed by one or more depressive stretches of time.
Progression: Relatively good, may last 6 months or 25% go to PTSD or Major Depressive Disorder
Causes:
Medications:Can be reduced by other prescribed drugs.
Therapies:
Youtube Video: Faces of Bipolar Disorder (PART 2) “Bipolar Type 1”
Amazon or Library Book: Bipolar Disorder 1
How to Survive and Thrive
Click the book to link or order from Amazon.
Support Group: dsballiance.org; 800-326-3632
(Depression and Bipolar Support Alliance)
Contact your local Social Security offic for possible Disability Benefits through their Disability Determination Services,
Section 12.04.
Resources for Physicians, Counselors and Researchers
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- Error monitoring and response inhibition in adolescents with bipolar disorders: An ERP studyby Kasey Stack on December 20, 2024
Cognitive control develops throughout adolescence, a high-risk period for bipolar disorders (BD) onset. Despite neurobehavioral abnormalities in adults with BD, there is minimal research investigating deviations in cognitive control in adolescents with BD. Cognitive control involves numerous processes. Identifying the specific neural abnormalities in adolescent BD could provide precise targets for novel interventions that improve illness outcomes. The present study administered a Go/No-Go (GNG)...
- Mood instability and risk of gastrointestinal diseases - a univariable and multivariable mendelian randomization studyby Rui-Lin Liu on December 20, 2024
CONCLUSION: This study provides compelling evidence for a potential causal relationship between mood instability and certain gastrointestinal diseases underscoring the importance of considering mood instability as a potential risk factor for gastrointestinal diseases as well as the positive role of maintaining mood stability in the prevention of gastrointestinal disorders.
- Stigma Toward Bipolar Disorder Among Psychiatry Residents: A Pilot Study Utilizing Narrative Medicine and a Video Vignetteby Marsal Sanches on December 20, 2024
CONCLUSION: The findings demonstrate the feasibility of implementing narrative medicine workshops for psychiatry residents and highlight the need for further studies with larger samples and a control group to evaluate its impact on stigma.
- The emerging role of long non-coding RNA SOX2-OT in cancers and non-malignant diseasesby Jingjie Yang on December 20, 2024
SOX2 overlapping transcript (SOX2-OT) is a long non-coding RNA located at chromosome 3q26.33 in humans. Convincing data confirm that SOX2-OT is evolutionarily conserved and plays a significant role in various malignant and non-malignant diseases. In most cancers, the upregulation of SOX2-OT acts as an oncogenic factor, strongly correlating with tumor risk, adverse clinicopathological features, and poor prognosis. Mechanistically, SOX2-OT is regulated by seven transcription factors and influences...